Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Em.bi.ji Group | Beauty & Personal Care | 24.1% | 83rd pct | 35 |
| Pregrans Vorld | Beauty & Personal Care | 13.1% | 54th pct | 35 |
| New Vizhen Kosmetiks | Beauty & Personal Care | 10.9% | 49th pct | 35 |
| Parpiumi | Beauty & Personal Care | 9.0% | 40th pct | 35 |
| Parmasi + | Beauty & Personal Care | 6.0% | 29th pct | 35 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
| Ratio — FY 2024 | New Vizhen Kosmetiks | Parpiumi | Parmasi + | Pregrans Vorld | Em.bi.ji Group |
|---|---|---|---|---|---|
| Margins | |||||
| Gross Margin | 45.3% | 67.5% | 52.6% | 26.5% | 38.7% |
| EBITDA Margin | 10.9% | 9.0% | 6.0% | 13.1% | 24.1% |
| EBITDAR | 428 | 339 | 229 | 339 | 616 |
| EBITDAR Margin | 12.8% | 10.6% | 7.3% | 13.1% | 26.5% |
| EBIT Margin | 10.1% | 8.8% | 4.5% | 12.9% | 23.8% |
| Net Profit Margin | 10.1% | 7.7% | 3.7% | 12.9% | 23.8% |
| Operating Expense % of Sales | 34.4% | 58.6% | 46.6% | 13.4% | 14.6% |
| Returns | |||||
| Return on Assets (ROA) | 14.2% | 11.9% | 8.9% | 13.0% | 23.5% |
| Return on Equity (ROE) | 14.9% | 16.7% | 13.9% | 27.9% | 23.9% |
| ROIC [EBIT / Invested Capital] | 19.4% | 15.0% | 11.8% | 34.6% | 32.5% |
| Leverage & debt balances | |||||
| Debt-to-Assets | 0.0% | 27.6% | 34.3% | 0.0% | 0.1% |
| Debt-to-Equity | 0.00x | 0.39x | 0.54x | 0.00x | 0.00x |
| Debt-to-EBITDA | 0.00x | 2.01x | 2.34x | 0.00x | 0.01x |
| Equity-to-Assets | 95.4% | 70.9% | 64.1% | 46.7% | 98.5% |
| Net Debt | -537 | 389 | 383 | -235 | -613 |
| Cash & Equivalents | 538 | 185 | 58 | 235 | 616 |
| Total Debt | 1 | 574 | 441 | N/A | 3 |
| Liquidity & working capital | |||||
| Current Ratio | 20.25x | 9.87x | 2.04x | 0.47x | 63.95x |
| Quick Ratio | 20.25x | 9.87x | 2.04x | 0.47x | 63.95x |
| Cash Ratio | 4.89x | 9.13x | 0.13x | 0.09x | 16.94x |
| Total Current Assets | 2,226 | 201 | 943 | 1,208 | 2,325 |
| Total Current Liabilities | 110 | 20 | 462 | 2,559 | 36 |
| Inventory | N/A | N/A | N/A | N/A | N/A |
| Trade Receivables | 962 | 1,653 | 72 | 28 | 532 |
| Trade Payables | 84 | 20 | N/A | 1,313 | 33 |
| Net Working Capital | 2,116 | 180 | 481 | -1,351 | 2,289 |
| Net Working Capital % of Revenue | 63.2% | 5.6% | 15.3% | -52.1% | 98.5% |
| Trade Working Capital | 878 | 1,632 | 72 | -1,285 | 499 |
| Trade Working Capital % of Revenue | 26.2% | 51.1% | 2.3% | -49.5% | 21.5% |
| Change in Trade Working Capital | N/A | N/A | N/A | N/A | N/A |
| Turnover & efficiency | |||||
| Inventory Turnover | N/A | N/A | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | N/A | N/A | N/A | N/A |
| Receivables Turnover | 3.48x | 1.93x | 43.58x | 91.57x | 4.37x |
| Days Sales Outstanding (DSO) | 104.8 | 188.9 | 8.4 | 4.0 | 83.6 |
| Payables Turnover | 21.80x | 51.04x | N/A | 1.45x | 43.09x |
| Days Payable Outstanding (DPO) | 16.7 | 7.2 | N/A | 251.4 | 8.5 |
| Cash Conversion Cycle | 88.1 days | 181.8 days | 8.4 days | -247.4 days | 75.1 days |
| Asset Turnover | 1.40x | 1.53x | 2.44x | 1.01x | 0.99x |
| Cash flow & dividends | |||||
| Operating Cash Flow | 448 | N/A | N/A | 95 | -335 |
| Free Cash Flow (OCF − Capex proxy) | 405 | N/A | N/A | 95 | -335 |
| Cash Conversion (OCF / EBITDA) | 122.9% | N/A | N/A | 28.1% | -60.0% |
| Dividends Declared | N/A | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A |